Increasingly, mesenchymal stem cells are being proposed as agents for cell-based therapies, due to their plasticity, established isolation procedures, and capacity for ex vivo expansion.

NFB is also developing cell-based therapies for tendon repair.

These studies will provide a foundation for a targeted and comprehensive analysis of the potential of a cell-based therapy for Canavan Disease.

Derivation and performance of an entirely autologous injectable hydrogel delivery system for cell-based therapies.

Chemical approaches to stem-cell biology support the development of cell-based therapies by enhancing stem-cell growth, maintenance, and differentiation in vitro.

This is one of the potentially viable means to overcome immune barriers to cell-based therapies for a variety of dire diseases.

In another scenario, genetically-customized stem cell lines would be generated for cell-based therapies to transplant to the patient.

For example, it is used in the process of producing knockout mice, as well as in tumor treatment, gene therapy, and cell-based therapy.

The use of progressive treatments, including gene- and cell-based therapies as well as tissue engineering, are innovative developments that give great hope to patients.

Gene- and cell-based therapies are emerging as new approaches.